New method of measuring subjective well-being: prospective validation study of the 'Daily Experience Sampling Questionnaire' (DESQ) in patients with psoriasis and healthy subjects in Germany.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
01 12 2020
Historique:
entrez: 2 12 2020
pubmed: 3 12 2020
medline: 15 5 2021
Statut: epublish

Résumé

To validate the newly developed Daily Experience Sampling Questionnaire (DESQ) that measures affective subjective well-being (SWB). The DESQ is an end-of-day diary in which respondents retrospectively rate their SWB at six different, randomly determined moments; it is completed over 1 week. The DESQ shall provide an alternative or complementary approach to existing methods of near-time SWB measurement (experience sampling, Day Reconstruction Method). The primary research objective was to determine criterion validity of the DESQ. Prospective, non-interventional study. Participants were recruited in Hamburg, Germany, at a specialised outpatient clinic (patients) and via different channels (healthy participants). 101 adults with diagnosed and stable psoriasis (46 women, 55 men); 105 adults without psoriasis (49 women, 56 men). Participants completed the DESQ for 3 weeks. In weeks 2 and 3, they also performed experience sampling. Criterion validity was determined by weekwise intraclass correlations (ICC) between both methods. Sensitivity to change was determined by the correlation between changes in both methods from weeks 2 to 3. For convergent validity, related concepts such as life satisfaction were measured. Retest reliability was determined using DESQ values of weeks 2 and 3. Criterion validity was excellent (ICC: patients=0.86, 95% CI 0.81 to 0.91; healthy participants=0.86, 95% CI 0.79 to 0.91). Sensitivity to change was r=0.57 and r=0.56, respectively. Correlations with convergent criteria were mostly significant and higher in constructs more proximal to SWB. The ICC indicating retest reliability was 0.77 in patients (95% CI 0.68 to 0.84) and 0.81 in healthy participants (95% CI 0.73 to 0.86). The DESQ is a valid, reliable and feasible instrument for SWB measurement in people with psoriasis and healthy people. Its approach of end-of-day evaluations of single moments may also lend itself to the measurement of other highly time-variant constructs such as pain, fatigue or depression.

Identifiants

pubmed: 33262188
pii: bmjopen-2020-039227
doi: 10.1136/bmjopen-2020-039227
pmc: PMC7709519
doi:

Types de publication

Clinical Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e039227

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Value Health. 2015 Jan;18(1):110-5
pubmed: 25595241
World Psychiatry. 2017 Jun;16(2):144-145
pubmed: 28498583
Qual Life Res. 2017 Sep;26(9):2251-2264
pubmed: 28324322
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
J Eur Acad Dermatol Venereol. 2017 Feb;31(2):205-212
pubmed: 27573025
J Pers Assess. 1985 Feb;49(1):71-5
pubmed: 16367493
J Pers Soc Psychol. 1993 Jul;65(1):45-55
pubmed: 8355141
Soc Indic Res. 2017 Jan;130(1):213-232
pubmed: 30532344
Dermatol Clin. 2012 Apr;30(2):231-6, xiii
pubmed: 22284137
Front Psychol. 2019 Jul 19;10:1698
pubmed: 31379699
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1331-1339
pubmed: 31838769
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Eur J Health Econ. 2005 Jun;6(2):124-30
pubmed: 19787848
Science. 2004 Dec 3;306(5702):1776-80
pubmed: 15576620
Qual Life Res. 2016 May;25(5):1103-12
pubmed: 26563251
Pers Soc Psychol Rev. 2015 Aug;19(3):235-56
pubmed: 25253069
Health Qual Life Outcomes. 2012 Nov 16;10:134
pubmed: 23158687
Psychol Bull. 2015 Jul;141(4):901-30
pubmed: 25822133
Pharmacoeconomics. 2012 Nov 1;30(11):1005-13
pubmed: 22994598
Orthopade. 2012 Apr;41(4):303-10
pubmed: 22476421
Arthritis Rheum. 2003 Apr 15;49(2):156-63
pubmed: 12687505
Dermatology. 2004;209(1):14-20
pubmed: 15237262
Psychol Aging. 2011 Mar;26(1):21-33
pubmed: 20973600

Auteurs

Christine Blome (C)

Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany c.blome@uke.de.

Natalia Kirsten (N)

Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

Ibrahim Nergiz (I)

Center for Dental and Oral Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

Ulrich Schiffner (U)

Center for Dental and Oral Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

Marina Otten (M)

Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

Matthias Augustin (M)

Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH